Literature DB >> 34248462

AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2021.

Nina Ditsch1, Cornelia Kolberg-Liedtke2, Michael Friedrich3, Christian Jackisch4, Ute-Susann Albert5, Maggie Banys-Paluchowski6,7, Ingo Bauerfeind8, Jens-Uwe Blohmer9, Wilfried Budach10, Peter Dall11, Eva M Fallenberg12, Peter A Fasching13, Tanja Fehm14, Bernd Gerber15, Oleg Gluz16, Nadia Harbeck17, Jörg Heil18, Jens Huober19, Hans-Heinrich Kreipe20, David Krug21, Thorsten Kühn22, Sherko Kümmel23, Sibylle Loibl24, Diana Lüftner25, Michael P Lux26, Nicolai Maass1, Christoph Mundhenke2, Ulrike Nitz16, Tjoung-Won Park-Simon3, Toralf Reimer15, Kerstin Rhiem4, Achim Rody6, Marcus Schmidt5, Andreas Schneeweiss6, Florian Schütz7, Hans-Peter Sinn8, Christine Solbach10, Erich-Franz Solomayer11, Elmar Stickeler12, Christoph Thomssen13, Michael Untch14, Isabell Witzel15, Achim Wöckel5, Volkmar Müller15, Wolfgang Janni16, Marc Thill17.   

Abstract

Entities:  

Year:  2021        PMID： 34248462      PMCID： PMC8248778          DOI： 10.1159/000516419

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.268


× No keyword cloud information.
  69 in total

1.  Papillary lesions of the breast: To excise or observe?

Authors:  Sidrah Khan; Adrian Diaz; Kellie J Archer; Rebecca R Lehman; Tiffany Mullins; Gilda Cardenosa; Harry D Bear
Journal:  Breast J       Date:  2017-08-27       Impact factor: 2.431

2.  Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: A randomized clinical trial of KROG 15-03.

Authors:  Kyu Hye Choi; Sung Ja Ahn; Jae Uk Jeong; Mina Yu; Jin Hee Kim; Bae Kwon Jeong; Joo Hwan Lee; Sung Hwan Kim; Jong Hoon Lee
Journal:  Radiother Oncol       Date:  2020-09-24       Impact factor: 6.280

Review 3.  Hepatitis B virus reactivation in breast cancer patients undergoing chemotherapy: A review and meta-analysis of prophylaxis management.

Authors:  Z Liu; L Jiang; G Liang; E Song; W Jiang; Y Zheng; C Gong
Journal:  J Viral Hepat       Date:  2017-02-05       Impact factor: 3.728

4.  The risk of developing breast, ovarian, and endometrial cancer in obese women submitted to bariatric surgery: a meta-analysis.

Authors:  Beatriz P Ishihara; Daniela Farah; Marcelo C M Fonseca; Afonso Nazario
Journal:  Surg Obes Relat Dis       Date:  2020-06-14       Impact factor: 4.734

5.  Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.

Authors:  Armando E Giuliano; Karla V Ballman; Linda McCall; Peter D Beitsch; Meghan B Brennan; Pond R Kelemen; David W Ollila; Nora M Hansen; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Kelly K Hunt; Monica Morrow
Journal:  JAMA       Date:  2017-09-12       Impact factor: 56.272

6.  Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Authors:  Hironobu Hashimoto; Masakazu Abe; Osamu Tokuyama; Hideaki Mizutani; Yosuke Uchitomi; Takuhiro Yamaguchi; Yukari Hoshina; Yasuhiko Sakata; Takako Yanai Takahashi; Kazuhisa Nakashima; Masahiko Nakao; Daisuke Takei; Sadamoto Zenda; Koki Mizukami; Satoru Iwasa; Michiru Sakurai; Noboru Yamamoto; Yuichiro Ohe
Journal:  Lancet Oncol       Date:  2019-12-11       Impact factor: 41.316

Review 7.  Breast lesions of uncertain malignant nature and limited metastatic potential: proposals to improve their recognition and clinical management.

Authors:  Emad A Rakha; Sunil Badve; Vincenzo Eusebi; Jorge S Reis-Filho; Stephen B Fox; David J Dabbs; Thomas Decker; Zsolt Hodi; Shu Ichihara; Andrew H S Lee; José Palacios; Andrea L Richardson; Anne Vincent-Salomon; Fernando C Schmitt; Puay-Hoon Tan; Gary M Tse; Ian O Ellis
Journal:  Histopathology       Date:  2016-01       Impact factor: 5.087

8.  The run-in phase of the prospective WSG-ADAPT HR+/HER2- trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.

Authors:  Ulrike Nitz; Oleg Gluz; Hans H Kreipe; Matthias Christgen; Sherko Kuemmel; Frederick L Baehner; Steven Shak; Bahriye Aktas; Michael Braun; Kerstin Lüdtke-Heckenkamp; Helmut Forstbauer; Eva-Maria Grischke; Benno Nuding; Maren Darsow; Claudia Schumacher; Katja Krauss; Wolfram Malter; Marc Thill; Mathias Warm; Rachel Wuerstlein; Ronald E Kates; Nadia Harbeck
Journal:  Ther Adv Med Oncol       Date:  2020-11-23       Impact factor: 8.168

9.  Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Women With Triple-Negative Breast Cancer: A Phase 3 Randomized Clinical Trial.

Authors:  Ke-Da Yu; Fu-Gui Ye; Min He; Lei Fan; Ding Ma; Miao Mo; Jiong Wu; Guang-Yu Liu; Gen-Hong Di; Xiao-Hua Zeng; Ping-Qing He; Ke-Jin Wu; Yi-Feng Hou; Jie Wang; Cheng Wang; Zhi-Gang Zhuang; Chuan-Gui Song; Xiao-Yan Lin; Angela Toss; Francesco Ricci; Zhen-Zhou Shen; Zhi-Ming Shao
Journal:  JAMA Oncol       Date:  2020-09-01       Impact factor: 31.777

10.  Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).

Authors:  Stephen R D Johnston; Nadia Harbeck; Roberto Hegg; Masakazu Toi; Miguel Martin; Zhi Min Shao; Qing Yuan Zhang; Jorge Luis Martinez Rodriguez; Mario Campone; Erika Hamilton; Joohyuk Sohn; Valentina Guarneri; Morihito Okada; Frances Boyle; Patrick Neven; Javier Cortés; Jens Huober; Andrew Wardley; Sara M Tolaney; Irfan Cicin; Ian C Smith; Martin Frenzel; Desirée Headley; Ran Wei; Belen San Antonio; Maarten Hulstijn; Joanne Cox; Joyce O'Shaughnessy; Priya Rastogi
Journal:  J Clin Oncol       Date:  2020-09-20       Impact factor: 50.717
View more
  12 in total

1.  Expert Discussion: Ductal Carcinoma in situ.

Authors:  Peter Dall; Jörg Heil; Maggie Banys-Paluchowski; David Krug; Wilfried Budach; Cornelia Kolberg-Liedtke; Toralf Reimer
Journal:  Breast Care (Basel)       Date:  2021-11-11       Impact factor: 2.860

2.  Staging for Breast Cancer: A Nationwide Survey about Adherence to Guidelines in German Breast Centers.

Authors:  Marcus Jannes; Alexander König; Martin Kolben; Claudius Fridrich; Verena Kirn
Journal:  Breast Care (Basel)       Date:  2022-01-14       Impact factor: 2.268

3.  Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.

Authors:  Cornelia Kolberg-Liedtke; Diana Lüftner; Sara Y Brucker; Wilfried Budach; Carsten Denkert; Peter A Fasching; Renate Haidinger; Nadia Harbeck; Jens Huober; Christian Jackisch; Wolfgang Janni; David Krug; Thorsten Kühn; Sibylle Loibl; Volkmar Müller; Andreas Schneeweiss; Christoph Thomssen; Michael Untch; Marc Thill
Journal:  Breast Care (Basel)       Date:  2022-04-08       Impact factor: 2.268

4.  Evaluation of a Wireless Localization System for Nonpalpable Breast Lesions - Feasibility and Cost-effectiveness in Everyday Clinical Routine.

Authors:  Patrik Pöschke; Julius Emons; Felix Heindl; Rüdiger Schulz-Wendtland; Sebastian Jud; Ramona Erber; Carolin C Hack; Caroline Preuss; Annika Behrens
Journal:  In Vivo       Date:  2022 Sep-Oct       Impact factor: 2.406

5.  Expert Discussion: Hypofractionated Radiation Therapy - Standard for All Indications?

Authors:  Gerd Fastner; David Krug; Icro Meattini; Günther Gruber; Philip Poortmans
Journal:  Breast Care (Basel)       Date:  2021-12-20       Impact factor: 2.268

6.  Incidental irradiation of the regional lymph nodes during deep inspiration breath-hold radiation therapy in left-sided breast cancer patients: a dosimetric analysis.

Authors:  Jule Wolf; Steffen Kurz; Thomas Rothe; Marco Serpa; Jutta Scholber; Thalia Erbes; Eleni Gkika; Dimos Baltas; Vivek Verma; David Krug; Ingolf Juhasz-Böss; Anca-Ligia Grosu; Nils H Nicolay; Tanja Sprave
Journal:  BMC Cancer       Date:  2022-06-21       Impact factor: 4.638

7.  Hair safe study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer patients receiving chemotherapy - A prospective interventional study.

Authors:  Christine Brunner; Miriam Emmelheinz; Ricarda Kofler; Samira Abdel Azim; Marlene Lehmann; Verena Wieser; Magdalena Ritter; Anne Oberguggenberger; Christian Marth; Daniel Egle
Journal:  Breast       Date:  2022-04-30       Impact factor: 4.254

8.  Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer.

Authors:  Sibylle Loibl; Jenny Furlanetto
Journal:  Breast       Date:  2021-12-13       Impact factor: 4.254

9.  Pyrotinib-Containing Neoadjuvant Therapy in Patients With HER2-Positive Breast Cancer: A Multicenter Retrospective Analysis.

Authors:  Xiaoyun Mao; Pengwei Lv; Yiping Gong; Xiujuan Wu; Peng Tang; Shushu Wang; Dianlong Zhang; Wei You; Ouchen Wang; Jun Zhou; Jingruo Li; Feng Jin
Journal:  Front Oncol       Date:  2022-04-07       Impact factor: 5.738

Review 10.  Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies.

Authors:  Natalia Krawczyk; Tanja Fehm; Eugen Ruckhaeberle; Laura Brus; Valeria Kopperschmidt; Achim Rody; Lars Hanker; Maggie Banys-Paluchowski
Journal:  Cancers (Basel)       Date:  2022-06-18       Impact factor: 6.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.